Notes for P&L
Note 6. Earnings per share
| 3 months | 12 months | ||
|---|---|---|---|
| 2026/27 | 2025/26 | 2025/26 | |
| Consolidated profit/loss for the period, SEK thousand | 872 | -9 961 | -46 338 |
| Weighted average number of shares before dilution | 26 667 910 | 21 334 328 | 23 423 923 |
| Outstanding shares at period-end | 26 667 910 | 21 334 328 | 26 667 910 |
| Dilution effect of option programs | - | - | - |
| Weighted average number of shares after dilution | 26 667 910 | 21 334 328 | 23 423 923 |
| Earnings per share before dilution | 0.03 | -0.47 | -1.98 |
| Earnings per share after dilution * | 0.03 | -0.47 | -1.98 |
* The comparative figure for diluted earnings per share has been adjusted to reflect that the outstanding share warrants were anti-dilutive during the comparative period.
Share warrant program
As of the reporting date, 1,325,791 warrants were outstanding under the Group’s incentive programs. In the calculation of diluted earnings per share, consideration is given to the exercise price of the warrants in relation to the average share price during the period, as well as the profit or loss for the period. If the period result is negative, or if the exercise price of the warrants exceeds the average share price, the warrants are considered anti-dilutive and are therefore excluded from the calculation.
All outstanding warrants were anti-dilutive during the period and have therefore not been included in the calculation of diluted earnings per share.